Can Dayvigo (lemborexant) cause ocular problems?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ocular Problems Associated with Dayvigo (Lemborexant)

Dayvigo (lemborexant) is not associated with any specific ocular problems based on current evidence and drug information.

Understanding Dayvigo and Ocular Effects

  • Dayvigo (lemborexant) is a sleep medication that works as an orexin receptor antagonist, and unlike some other medications, it has not been documented to cause specific ocular side effects 1
  • This contrasts with medications like dupilumab which has well-documented ocular surface disorders including conjunctivitis, dry eye, keratitis, and blepharitis 1

Comparison with Medications Known to Cause Ocular Problems

  • Many psychotropic medications and sleep aids can cause ocular side effects, but Dayvigo is not among those specifically identified in the literature 2, 3
  • For example, certain antiepileptic drugs can cause visual disturbances including diplopia, blurred vision, and nystagmus 4, 5
  • Some medications like phenothiazines and lithium can cause eyelid and keratoconjunctival disorders 2
  • Topiramate has been associated with acute angle-closure glaucoma, which is not reported with Dayvigo 6

Monitoring Recommendations

  • While specific ocular problems are not documented with Dayvigo, general vigilance for any unexpected side effects is always prudent when starting a new medication 3
  • If patients report any visual disturbances while taking Dayvigo, they should be evaluated by an ophthalmologist to rule out other causes 1
  • This differs from medications like dupilumab where specific monitoring for conjunctivitis (occurring in 6-15% of patients) and other ocular surface disorders is recommended 7

Clinical Perspective

  • The absence of documented ocular side effects makes Dayvigo a potentially favorable option for patients with pre-existing ocular conditions who need sleep medication 2, 3
  • This contrasts with medications that have known ocular effects, such as certain antipsychotics that can cause cataracts or retinopathy with long-term use 2
  • When prescribing any sleep medication, including Dayvigo, standard precautions regarding CNS depression and potential for falls should still be considered, though these are not specifically ocular concerns 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Drug-induced ocular disorders.

Drug safety, 2008

Guideline

Adverse Effects of Dupilumab

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.